Mississippi Announces Major Cannabis Rule Revisions
Mississippi's Department of Health has unveiled extensive revisions to cannabis industry regulations, seeking public input until Oct. 2.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporation as the sole agent and sole book-runner on a "best efforts" agency basis in connection with a marketed private placement offering of units of the company
The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit.
South Korean police accused 17 U.S. soldiers and five others of illegally distributing or consuming synthetic cannabis. The New York Times reported the substance was being smuggled in via the U.S.
Will New York cannabis regulators ever catch a break from lawsuits?
Not in the near future, it seems.
What happened: Large marijuana e-commerce platform Leafly Holdings (NASDAQ: LFLY)
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) is expanding its cannabis brand portfolio in the Sunshine State to include the FloraCal and Cresco brands.